Table of Contents
New Journal of Science
Volume 2014, Article ID 932342, 6 pages
http://dx.doi.org/10.1155/2014/932342
Review Article

MicroRNAs as Potential Biomarkers in Acute Promyelocytic Leukaemia

1Department of Haematology, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, 16150 Kubang Kerian, Kelantan, Malaysia
2Faculty of Medicine and Health Sciences, Universiti Sultan Zainal Abidin, 20400 Kuala Terengganu, Terengganu, Malaysia
3Human Genome Centre, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, 16150 Kubang Kerian, Kelantan, Malaysia

Received 24 June 2014; Revised 28 October 2014; Accepted 20 November 2014; Published 7 December 2014

Academic Editor: Alfredo Pulvirenti

Copyright © 2014 Imilia Ismail et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. W. Vardiman, J. Thiele, D. A. Arber et al., “The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes,” Blood, vol. 114, no. 5, pp. 937–951, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. B.-W. Gu, H. Xiong, Y. Zhou et al., “Variant-type PML-RARα fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RARα gene and identification of a new clinical subtype resistant to retinoic acid therapy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 11, pp. 7640–7645, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. P. C. Choppa, J. Gomez, H. G. Vall, M. Owens, H. Rappaport, and J. R. Lopategui, “A novel method for the detection, quantitation, and breakpoint cluster region determination of t(15;17) fusion transcripts using a one-step real-time multiplex RT-PCR,” American Journal of Clinical Pathology, vol. 119, no. 1, pp. 137–144, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Chatterjee, S. Gupta, S. Sharma, and P. Ganguli, “Distribution of different PML/RARα bcr isoforms in Indian acute promyelocytic leukemia (APL) patients and clinicohematological correlation,” Mediterranean Journal of Hematology and Infectious Diseases, vol. 6, no. 1, Article ID e2014004, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Lo-Coco, M. Breccia, and D. Diverio, “The importance of molecular monitoring in acute promyelocytic leukaemia,” Best Practice and Research: Clinical Haematology, vol. 16, no. 3, pp. 503–520, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. B. A. Hassan, A. D. Abdullah, A. Husin et al., “Characterizing PML/RARA isoforms of Acute Promyelocytic Leukemia (APL) in Malay patients,” Bangladesh Journal of Medical Science, vol. 13, no. 3, pp. 311–315, 2014. View at Google Scholar
  7. J. Batliner, E. Buehrer, M. F. Fey, and M. P. Tschan, “Inhibition of the miR-143/145 cluster attenuated neutrophil differentiation of APL cells,” Leukemia Research, vol. 36, no. 2, pp. 237–240, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Braeuer-Hartmann, J.-U. Hartmann, D. Gerloff et al., “PML/RARα -regulated microRNA 181b targets the tumor suppressor RASSF1A in acute promyelocytic leukemia,” ASH Annual Meeting Abstract, vol. 118, no. 21, p. 1361, 2011. View at Google Scholar
  9. R. Garzon, F. Pichiorri, T. Palumbo et al., “MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia,” Oncogene, vol. 26, no. 28, pp. 4148–4157, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Saumet, G. Vetter, M. Bouttier et al., “Transcriptional repression of microRNA genes by PML-RARA increases expression of key cancer proteins in acute promyelocytic leukemia,” Blood, vol. 113, no. 2, pp. 412–421, 2009. View at Publisher · View at Google Scholar
  11. M. Sharifi, R. Salehi, Y. Gheisari, and M. Kazemi, “Inhibition of microRNA miR-92a induces apoptosis and inhibits cell proliferation in human acute promyelocytic leukemia through modulation of p63 expression,” Molecular Biology Reports, vol. 41, no. 5, pp. 2799–10, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. R. I. Gregory and R. Shiekhattar, “MicroRNA biogenesis and cancer,” Cancer Research, vol. 65, no. 9, pp. 3509–3512, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. C.-Z. Chen, “MicroRNAs as oncogenes and tumor suppressors,” The New England Journal of Medicine, vol. 353, no. 17, pp. 1768–1771, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Laganà, F. Russo, C. Sismeiro, R. Giugno, A. Pulvirenti, and A. Ferro, “Variability in the incidence of miRNAs and genes in fragile sites and the role of repeats and CpG islands in the distribution of genetic material,” PLoS ONE, vol. 5, no. 6, Article ID e11166, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Lopez-Serra and M. Esteller, “DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer,” Oncogene, vol. 31, no. 13, pp. 1609–1622, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Akhavantabasi, A. Sapmaz, S. Tuna, and A. E. Erson-Bensan, “MiR-125b targets ARID3B in breast cancer cells,” Cell Structure and Function, vol. 37, no. 1, pp. 27–38, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. N.-S. A. Mutalib, C. Yoke-Kqueen, S. A. Rahman, S. M. Sidik, A. S. M. Singh, and L. Learn-Han, “Differential microRNA expression and identification of putative miRNA targets and pathways in head and neck cancers,” International Journal of Molecular Medicine, vol. 28, no. 3, pp. 327–336, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Saito, G. Liang, G. Egger et al., “Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells,” Cancer Cell, vol. 9, no. 6, pp. 435–443, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Takamizawa, H. Konishi, K. Yanagisawa et al., “Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival,” Cancer Research, vol. 64, no. 11, pp. 3753–3756, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Weber, M. B. Baker, R. S. Patel, A. A. Quyyumi, G. Bao, and C. D. Searles, “MicroRNA expression profile in CAD patients and the impact of ACEI/ARB,” Cardiology Research and Practice, vol. 2011, Article ID 532915, 5 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. W. Wu, J. Yang, X. Feng et al., “MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells,” Molecular Cancer, vol. 12, no. 1, article 30, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Volinia, G. A. Calin, C.-G. Liu et al., “A microRNA expression signature of human solid tumors defines cancer gene targets,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 7, pp. 2257–2261, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. D. L. Zanette, F. Rivadavia, G. A. Molfetta et al., “miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia,” Brazilian Journal of Medical and Biological Research, vol. 40, no. 11, pp. 1435–1440, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Chen, Q. Chen, M. Fang, and Y. Mi, “microRNA-181b targets MLK2 in HL-60 cells,” Science China Life Sciences, vol. 53, no. 1, pp. 101–106, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Zhang, X.-Q. Luo, D.-D. Feng et al., “Upregulation of microRNA-125b contributes to leukemogenesis and increases drug resistance in pediatric acute promyelocytic leukemia,” Molecular Cancer, vol. 10, article 108, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Dixon-McIver, P. East, C. A. Mein et al., “Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia,” PLoS ONE, vol. 3, no. 5, Article ID e2141, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. G. A. Calin, C. D. Dumitru, M. Shimizu et al., “Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 24, pp. 15524–15529, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Bonci, V. Coppola, M. Musumeci et al., “The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities,” Nature Medicine, vol. 14, no. 11, pp. 1271–1277, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Bandi, S. Zbinden, M. Gugger et al., “miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer,” Cancer Research, vol. 69, no. 13, pp. 5553–5559, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Bottoni, D. Piccin, F. Tagliati, A. Luchin, M. C. Zatelli, and E. C. D. Uberti, “miR-15a and miR-16-1 down-regulation in pituitary adenomas,” Journal of Cellular Physiology, vol. 204, no. 1, pp. 280–285, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Fabbri, A. Bottoni, M. Shimizu et al., “Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of b-cell chronic lymphocytic leukemia,” JAMA—Journal of the American Medical Association, vol. 305, no. 1, pp. 59–67, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Fazi, A. Rosa, A. Fatica et al., “A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPα regulates human granulopoiesis,” Cell, vol. 123, no. 5, pp. 819–831, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Metzler, M. Wilda, K. Busch, S. Viehmann, and A. Borkhardt, “High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma,” Genes Chromosomes and Cancer, vol. 39, no. 2, pp. 167–169, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Kluiver, S. Poppema, D. de Jong et al., “BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas,” Journal of Pathology, vol. 207, no. 2, pp. 243–249, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. P. S. Eis, W. Tam, L. Sun et al., “Accumulation of miR-155 and BIC RNA in human B cell lymphomas,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 10, pp. 3627–3632, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Marcucci, K. S. Maharry, K. H. Metzeler et al., “Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients,” Journal of Clinical Oncology, vol. 31, no. 17, pp. 2086–2093, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. R. M. O'Connell, K. D. Taganov, M. P. Boldin, G. Cheng, and D. Baltimore, “MicroRNA-155 is induced during the macrophage inflammatory response,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 5, pp. 1604–1609, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. D.-Q. Feng, B. Huang, J. Li et al., “Selective miRNA expression profile in chronic myeloid leukemia K562 cell-derived exosomes,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 12, pp. 7501–7508, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. M. C. Henderson and D. O. Azorsa, “The genomic and proteomic content of cancer cell-derived exosomes,” Frontiers in Oncology, vol. 2, article 38, Article ID 00038, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Inomata, H. Tagawa, Y.-M. Guo, Y. Kameoka, N. Takahashi, and K. Sawada, “MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes,” Blood, vol. 113, no. 2, pp. 396–402, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Tagawa, K. Karube, S. Tsuzuki, K. Ohshima, and M. Seto, “Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development,” Cancer Science, vol. 98, no. 9, pp. 1482–1490, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. K. A. O'Donnell, E. A. Wentzel, K. I. Zeller, C. V. Dang, and J. T. Mendell, “c-Myc-regulated microRNAs modulate E2F1 expression,” Nature, vol. 435, no. 7043, pp. 839–843, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Fontana, E. Pelosi, P. Greco et al., “MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation,” Nature Cell Biology, vol. 9, no. 7, pp. 775–787, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. Q. Wang, C. L. Yan, J. Wang et al., “miR-17-92 cluster accelerates adipocyte differentiation by negatively regulating tumor-suppressor Rb2/p130,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 8, pp. 2889–2894, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Debernardi, S. Skoulakis, G. Molloy, T. Chaplin, A. Dixon-McIver, and B. D. Young, “MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis,” Leukemia, vol. 21, no. 5, pp. 912–916, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Debernardi, D. M. Lillington, T. Chaplin et al., “Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion events,” Genes Chromosomes and Cancer, vol. 37, no. 2, pp. 149–158, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Castaigne, C. Chomienne, M. T. Daniel et al., “All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results,” Blood, vol. 76, no. 9, pp. 1704–1709, 1990. View at Google Scholar · View at Scopus
  49. G. Mann, D. Reinhardt, J. Ritter et al., “Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in children,” Annals of Hematology, vol. 80, no. 7, pp. 417–422, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Nervi, F. Fazi, A. Rosa, A. Fatica, and I. Bozzoni, “Emerging role for microRNAs in acute promyelocytic leukemia,” Current Topics in Microbiology and Immunology, vol. 313, pp. 73–84, 2007. View at Google Scholar · View at Scopus
  51. W. Wu, T. Pew, M. Zou, D. Pang, and S. D. Conzen, “Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival,” Journal of Biological Chemistry, vol. 280, no. 6, pp. 4117–4124, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. J. M. Kim, J. M. White, A. S. Shaw, and B. P. Sleckman, “MAPK p38α is dispensable for lymphocyte development and proliferation,” The Journal of Immunology, vol. 174, no. 3, pp. 1239–1244, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. J.-X. Guo, Q.-S. Tao, P.-R. Lou, X.-C. Chen, J. Chen, and G.-B. Yuan, “miR-181b as a potential molecular target for anticancer therapy of gastric neoplasms,” Asian Pacific Journal of Cancer Prevention, vol. 13, no. 5, pp. 2263–2267, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Bousquet, D. Nguyen, C. Chen, L. Shields, and H. F. Lodish, “MicroRNA-125b transforms myeloid cell lines by repressing multiple mRNA,” Haematologica, vol. 97, no. 11, pp. 1713–1721, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Tanaka, K. Oikawa, M. Takanashi et al., “Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients,” PLoS ONE, vol. 4, no. 5, Article ID e5532, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Yoshizawa, J. H. Ohyashiki, M. Ohyashiki et al., “Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders,” Blood Cancer Journal, vol. 2, no. 1, article e53, 2012. View at Publisher · View at Google Scholar · View at Scopus